|
"許輝吉"的相關文件
顯示項目 51-75 / 214 (共9頁)
<< < 1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2004 |
Allelic Loss of Chromosome 4q21 Approximate to 23 Associates with Hepatitis B Virus-Related Hepatocarcinogenesis and Elevated Alpha- Fetoprotein
|
葉秀慧; 林明薇; 呂淑芬; 蔡世峰; 蔡靜怡; 賴明陽; 許輝吉; 陳定信; 陳培哲; YEH, SHIOU-HWEI; LIN, MING-WEI; LU, SHU- FEN; TSAI, SHIH-FENG; TSAI, CHING-YI; LAI, MING-YANG; HSU, HEY-CHI; CHEN, DING-SHINN; CHEN, PEI-JER |
| 國立臺灣大學 |
2004 |
Microvessel Density, Cyclo-Oxygenase 2 Expression, K-Ras Mutation and P53 Overexpression in Colonic Cancer
|
梁金銅; 黃國晉; 鄭永銘; 李伯皇; 賴鴻緒; 許輝吉; LIANG, JIN-TUNG; HUANG, KUO-CHIN; JENG, YUNG-MING; LEE, PO-HUANG; LAI, HONG-SHIEE; HSU, HEY-CHI |
| 國立臺灣大學 |
2004 |
RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts
|
崔道真; 許輝吉; 李伯皇; 鄭永銘; 蒲永孝; 陳炯年; 李元麒; 倪衍玄; 張美惠; TSUEI, DAW-JEN; HSU, HEY-CHI; LEE, PO-HUANG; JENG, YUNG-MING; PU, YEONG-SHIAU; CHEN, CHIUNG-NIEN; LEE, YUNG-CHIE; NI, YEN- HSUAN; CHANG, MEI-HWEI |
| 國立臺灣大學 |
2004 |
Doxorubicin Activates Hepatitis B Virus (Hbv) Replication in Hbv- Harboring Hepatoblastoma Cells. A Possible Novel Mechanism of Hbv Reactivation in Hbv Carriers Receiving Systemic Chemotherapy
|
徐志宏; 許輝吉; 陳惠玲; 高明; 葉培彥; 陳培哲; 鄭安理; HSU, CHIH-HUNG; HSU, HEY-CHI; CHEN, HUI-LING; GAO, MING; YEH, PEI-YEN; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2004 |
Nuclear Expression of Bcl10 or Nuclear Factor Kappa B Predicts Helicobacter Pylori-Independent Status of Early-Stage, High-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphomas
|
郭頌鑫; 陳立宗; 葉坤輝; 吳明賢; 許輝吉; 葉培彥; 毛翠蓮; 陳志榮; 董馨蓮; 林肇堂; 鄭安理; KUO, SUNG-HSIN; CHEN, LI-TZONG; YEH, KUN-HUEI; WU, MING-SHIANG; HSU, HEY-CHI; YEH, PEI-YEN; MAO, TSUI-LIEN; CHEN, CHI-LONG; DOONG, SHIN-LIAN; LIN, JAW-TOWN; CHENG, ANN-LII |
| 國立臺灣大學 |
2003 |
行政院國家科學委員會專題研究計畫期中進度報告:新穎基因L2DTL在肝細胞癌之選殖與異常表現: 生物學意義(2/3)
|
許輝吉 |
| 國立臺灣大學 |
2003 |
行政院國家科學委員會補助專題研究計畫成果報告:基因剔除動物模式研究人類L2DTL/ramp基因
|
許輝吉 |
| 國立臺灣大學 |
2003 |
Changes in the Ratios of the Hdl-Apociii to Plasma-Apociii Associated with an Increased Risk of Coronary Artery Disease
|
李源德; 許輝吉; LEE, YUAN-TEH; HSU, HEY-CHI |
| 國立臺灣大學 |
2003 |
Tetrasomy 6 and 6q14 Deletion Are Associated with Better Survival in Hepatocellular Carcinomas: A Fluorescence in Situ Hybridization Study of 77 Cases
|
黃秀芬; 許輝吉; 季瑋珠; 賴寶蓮; HUANG, SHIU-FENG; HSU, HEY-CHI; CHIE, WEI-CHU; LAI, PO-LIN |
| 國立臺灣大學 |
2003 |
Klf6, a Putative Tumor Suppressor Gene, Is Mutated in Astrocytic Gliomas
|
鄭永銘; 許輝吉; JENG, YUNG-MING; HSU, HEY-CHI |
| 國立臺灣大學 |
2003 |
A Novel Genetic Variant in the Apolipoprotein A5 Gene Is Associated with Hypertriglyceridemia
|
高照村; 簡國龍; 許輝吉; 林淑華; KAO, JAU-TSUEN; CHIEN, KUO-LIONG; HSU, HEY-CHI; LIN, SHU-WHA |
| 國立臺灣大學 |
2003 |
Overexpression of Osteopontin Is Associated with Intrahepatic Metastasis, Early Recurrence, and Poorer Prognosis of Surgically Resected Hepatocellular Carcinoma
|
潘弘偉; 歐月星; 彭向陽; 賴寶蓮; 李伯皇; 許金川; 陳志榮; 許輝吉; PAN, HUNG-WEI; OU, YUEH-HSING; PENG, SHIAN-YANG; LAI, PO-LIN; LEE, PO-HUANG; SHEU, JIN-CHUAN; CHEN, CHI-LONG; HSU, HEY-CHI |
| 國立臺灣大學 |
2002 |
新穎基因L2DTL在肝細胞癌之選殖與異常表現: 生物學意義(1/3)
|
許輝吉 |
| 國立臺灣大學 |
2002 |
肝細胞癌B-catenin與互動因子之異常表現與突變的生物學意義（３／３）
|
許輝吉 |
| 國立臺灣大學 |
2002 |
Multidimensional Scaling Analysis of the Reproducibility of Histological Classification of Primary Liver Carcinomas Reveals the Need for Better International Criteria
|
許輝吉; HSU, HEY-CHI |
| 國立臺灣大學 |
2002 |
Mutation of the Dr5/Trail Receptor 2 Gene Is Infrequent in Hepatocellular Carcinoma
|
鄭永銘; 許輝吉; JENG, YUNG-MING; HSU, HEY-CHI |
| 國立臺灣大學 |
2002 |
Fic1 and Bsep Defects in Taiwanese Patients with Chronic Intrahepatic Cholestasis with Low γglutamyltranspeptidase Levels
|
陳慧玲; 張培鑫; 許輝吉; 倪衍玄; 許宏遠; 李志鴻; 鄭永銘; 邵文逸; 張美惠; CHEN, HUEY-LING; CHANG, PEI-SHIN; HSU, HEY-CHI; NI, YEN-HSUAN; HSU, HONG-YUAN; LEE, JIH-HORNG; JENG, YUNG-MING; SHAU, WEN-YI; CHANG, MEI-HWEI |
| 國立臺灣大學 |
2002 |
Mutations of the Adenomatous Polyposis Coli Gene in Areca Quid and Tobacco-Associated Oral Squamous Cell Carcinomas in Taiwan
|
郭生興; 李正; 許輝吉; 江俊斌; 郭英雄; 郭彥彬; KOK, SANG-HENG; LEE, JANG-JAER; HSU, HEY-CHI; CHIANG, CHUN-PIN; KUO, YING-SHIUNG; KUO, MARK YEN-PING |
| 國立臺灣大學 |
2002 |
P53 Overexpression Predicts Poor Chemosensitivity to High-Dose 5- Fluorouracil Plus Leucovorin Chemotherapy for Stage Iv Colorectal Cancers after Palliative Bowel Resection
|
梁金銅; 黃國晉; 鄭永銘; 許輝吉; 鄭安理; 徐志宏; 葉坤輝; 王世名; 張金堅; LIANG, JIN-TUNG; HUANG, KUO-CHIN; JENG, YUNG-MING; HSU, HEY-CHI; CHENG, ANN-LII; HSU, CHIH-HUNG; YEH, KUN-HUEI; WANG, SHIH-MING; CHANG, KING-JEN |
| 國立臺灣大學 |
2002 |
High-Frequency Microsatellite Instability Predicts Better Chemosensitivity to High-Dose 5-Fluorouracil Plus Leucovorin Chemotherapy for Stage Iv Sporadic Colorectal Cancer after Palliative Bowel Resection
|
梁金銅; 黃國晉; 賴鴻緒; 許輝吉; 徐志宏; LIANG, JIN-TUNG; HUANG, KUO-CHIN; LAI, HONG-SHIEE; HSU, HEY-CHI; HSU, CHIH-HUNG |
| 國立臺灣大學 |
2002 |
Expression of Epidermal Growth Factor Receptor in Head and Neck Cancers Correlates with Clinical Progression: A Multicentre Immunohistochemical Study in the Asia-Pacific Region
|
許輝吉; HSU, HEY-CHI |
| 國立臺灣大學 |
2002 |
Dominance of Functional Androgen Receptor Allele with Longer Cag Repeat in Hepatitis B Virus-Related Female Hepatocarcinogenesis
|
許輝吉; 李伯皇; 陳定信; 陳培哲; HSU, HEY-CHI; LEE, PO-HUANG; CHEN, DING- SHINN; CHEN, PEI-JER |
| 國立臺灣大學 |
2002 |
Down-Regulation of Annexin A10 in Hepatocellular Carcinoma Is Associated with Vascular Invasion, Early Recurrence, and Poor Prognosis in Synergy with P53 Mutation
|
鄭永銘; 賴寶蓮; 許輝吉; JENG, YUNG-MING; LAI, PO-LIN; HSU, HEY-CHI |
| 國立臺灣大學 |
2002 |
Her-2/Neu Overexpression Is Rare in Hepatocellular Carcinoma and Not Predictive of Anti-Her-2/Neu Regulation of Cell Growth and Chemosensitivity
|
許駿; 許輝吉; 鄭安理; HSU, CHIUN; HSU, HEY-CHI; CHENG, ANN-LII |
| 國立臺灣大學 |
2001 |
肝細胞癌B-catenin與互動因子之異常表現與突變的生物學意(2/3)
|
許輝吉 |
顯示項目 51-75 / 214 (共9頁)
<< < 1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目
|
